1143 related articles for article (PubMed ID: 1719267)
21. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.
Rogers PC; Olson TA; Cullen JW; Billmire DF; Marina N; Rescorla F; Davis MM; London WB; Lauer SJ; Giller RH; Cushing B; ;
J Clin Oncol; 2004 Sep; 22(17):3563-9. PubMed ID: 15337806
[TBL] [Abstract][Full Text] [Related]
22. [Therapy of testicular germ cell tumors. Current status of the MAHO studies].
Haas RJ; Schmidt P; Göbel U; Harms D
Klin Padiatr; 1993; 205(4):225-30. PubMed ID: 8397320
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S
Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427
[TBL] [Abstract][Full Text] [Related]
24. Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study.
Marina N; Chang KW; Malogolowkin M; London WB; Frazier AL; Womer RB; Rescorla F; Billmire DF; Davis MM; Perlman EJ; Giller R; Lauer SJ; Olson TA;
Cancer; 2005 Aug; 104(4):841-7. PubMed ID: 15999362
[TBL] [Abstract][Full Text] [Related]
25. Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.
Mardiak J; Sálek T; Sycová-Milá Z; Obertová J; Recková M; Mego M; Hlavatá Z; Brozmanová K; Risnyovzská Z; Svetlovská D; Koza I
Neoplasma; 2007; 54(3):240-5. PubMed ID: 17447857
[TBL] [Abstract][Full Text] [Related]
26. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
Haugnes HS; Laurell A; Stierner U; Bremnes RM; Dahl O; Cavallin-Ståhl E; Cohn-Cedermark G
Acta Oncol; 2012 Feb; 51(2):168-76. PubMed ID: 22175254
[TBL] [Abstract][Full Text] [Related]
27. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
28. Testicular germ cell tumors, an update. Results of the German cooperative studies 1982-1997.
Haas RJ; Schmidt P; Göbel U; Harms D
Klin Padiatr; 1999; 211(4):300-4. PubMed ID: 10472566
[TBL] [Abstract][Full Text] [Related]
29. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
[TBL] [Abstract][Full Text] [Related]
30. The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049/CCG 8882).
Rescorla F; Billmire D; Stolar C; Vinocur C; Colombani P; Cullen J; Giller R; Cushing B; Lauer S; Davis M; Hawkins E; Shuster J; Krailo M
J Pediatr Surg; 2001 Jan; 36(1):12-7. PubMed ID: 11150431
[TBL] [Abstract][Full Text] [Related]
31. Malignant mediastinal germ cell tumors: an intergroup study.
Billmire D; Vinocur C; Rescorla F; Colombani P; Cushing B; Hawkins E; London WB; Giller R; Lauer S
J Pediatr Surg; 2001 Jan; 36(1):18-24. PubMed ID: 11150432
[TBL] [Abstract][Full Text] [Related]
32. [The prognostic significance of serum alpha 1-fetoprotein in children and adolescents with malignant extracranial non-testicular germ cell tumors].
Calaminus G; Vesterling-Hörner D; Bökkerink JP; Gadner H; Günther G; Haas HJ; Jürgens H; Teske C; Göbel U
Klin Padiatr; 1991; 203(4):246-50. PubMed ID: 1719268
[TBL] [Abstract][Full Text] [Related]
33. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
Tandstad T; Dahl O; Cohn-Cedermark G; Cavallin-Stahl E; Stierner U; Solberg A; Langberg C; Bremnes RM; Laurell A; Wijkstrøm H; Klepp O
J Clin Oncol; 2009 May; 27(13):2122-8. PubMed ID: 19307506
[TBL] [Abstract][Full Text] [Related]
34. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
[TBL] [Abstract][Full Text] [Related]
35. Markedly improved survival in malignant sacro-coccygeal teratomas--16 years, experience.
Misra D; Pritchard J; Drake DP; Kiely EM; Spitz L
Eur J Pediatr Surg; 1997 Jun; 7(3):152-5. PubMed ID: 9241501
[TBL] [Abstract][Full Text] [Related]
36. Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96.
Biskup W; Calaminus G; Schneider DT; Leuschner I; Göbel U
Klin Padiatr; 2006; 218(6):303-8. PubMed ID: 17080331
[TBL] [Abstract][Full Text] [Related]
37. Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.
Dimopoulos MA; Papadimitriou C; Hamilos G; Efstathiou E; Vlahos G; Rodolakis A; Aravantinos G; Kalofonos H; Kouroussis C; Gika D; Skarlos D; Bamias A
Gynecol Oncol; 2004 Dec; 95(3):695-700. PubMed ID: 15581984
[TBL] [Abstract][Full Text] [Related]
38. [BEP (bleomycin, etoposide, cisplatinum) chemotherapy as an induction therapy of advanced extragonadal germ cell tumor].
Goto S; Fukui I; Ando M; Kihara K; Kitahara S; Tsujii T; Noro A; Hagiwara T; Toyoshima T; Tsukamoto T
Hinyokika Kiyo; 1991 Dec; 37(12):1689-93. PubMed ID: 1723842
[TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy in malignant non-seminomatous germ-cell tumors: results of a cooperative study of the German Society of Pediatric Oncology (MAKEI 83).
Gobel U; Calaminus G; Häas RJ; Jurgens H; Niethammer D; Ritter J; Spaar HJ; Harms D
Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S34-9. PubMed ID: 2547530
[TBL] [Abstract][Full Text] [Related]
40. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
